OncLive SOSS

Lower-Risk MDS: Current and Future Treatment Strategies - Episode 6

Clinical Implications of Recent Data on New Agents in Lower-Risk MDS

October 5, 2023

Uwe Platzbecker, MD, Rami Komrokji, MD, Valeria Santini, MD

Expert perspectives on the clinical implications of recent clinical trial data on new therapies in lower-risk myelodysplastic syndrome.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Myelodysplastic Syndrome: Overview of Diagnosis, Classification, and Treatment

EP. 2: Clinical Insights into the COMMANDS Trial

EP. 3: Lower-Risk MDS: How Do Practice Patterns Compare Worldwide?

EP. 4: MEDALIST Trial: Luspatercept in Patients with Lower-Risk MDS

EP. 5: Recent Updates for Second-Line Treatment Options in Lower-Risk MDS

EP. 6: Clinical Implications of Recent Data on New Agents in Lower-Risk MDS

EP. 7: Real-World Data for Luspatercept in Lower-Risk MDS

EP. 8: Treatment Strategies and Sequencing in MDS

EP. 9: Unmet Needs and Future of Lower-Risk MDS

x